Onyx Pharmaceuticals Announces Second Quarter 2004 Financial Results Webcast and Teleconference

Contact:
Julie Wood
510-262-8757

Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will webcast a teleconference discussing its second quarter 2004 financial results on Monday, August 9, 2004, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the second quarter ended June 30, 2004 will be released earlier that day.

Interested parties may access a live webcast of the presentation at:
http://audioevent.mshow.com/179451 or by dialing 706-679-4614 and using the passcode 9143944. A replay of the presentation will be available on the Onyx website or by dialing 706 645-9291 and using the passcode 9143944 approximately three hours after the teleconference concludes. The replay will be available through September 9, 2004.

Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at www.onyx-pharm.com.

Back to 2004 Press Releases